Graham S Jackson

Author PubWeight™ 36.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 2011 2.60
2 Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 2007 2.01
3 Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008 1.77
4 Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 2007 1.59
5 Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One 2010 1.25
6 Efficient dissemination of prions through preferential transmission to nearby cells. J Gen Virol 2007 1.15
7 The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J Biol Chem 2004 1.14
8 Elongated oligomers assemble into mammalian PrP amyloid fibrils. J Mol Biol 2006 1.10
9 PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J Gen Virol 2005 1.09
10 PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 2010 1.07
11 Modification of superoxide dismutase 1 (SOD1) properties by a GFP tag--implications for research into amyotrophic lateral sclerosis (ALS). PLoS One 2010 1.05
12 Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc Natl Acad Sci U S A 2009 1.04
13 Spontaneous generation of mammalian prions. Proc Natl Acad Sci U S A 2010 1.00
14 Definable equilibrium states in the folding of human prion protein. Biochemistry 2005 0.99
15 PrPSc binding antibodies are potent inhibitors of prion replication in cell lines. J Biol Chem 2004 0.99
16 The R1441C mutation alters the folding properties of the ROC domain of LRRK2. Biochim Biophys Acta 2009 0.98
17 Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J 2006 0.98
18 Protein conformation significantly influences immune responses to prion protein. J Immunol 2005 0.95
19 Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification. Transfusion 2010 0.94
20 A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K. Transfusion 2010 0.94
21 Folding kinetics of the human prion protein probed by temperature jump. Proc Natl Acad Sci U S A 2009 0.94
22 A reassessment of copper(II) binding in the full-length prion protein. Biochem J 2006 0.92
23 Pharmacological chaperone for the structured domain of human prion protein. Proc Natl Acad Sci U S A 2010 0.90
24 A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay. J Gen Virol 2010 0.90
25 Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc. Biochim Biophys Acta 2007 0.90
26 Recombinant prion protein does not possess SOD-1 activity. Biochem J 2005 0.87
27 Conformational properties of beta-PrP. J Biol Chem 2009 0.87
28 The legs at odd angles (Loa) mutation in cytoplasmic dynein ameliorates mitochondrial function in SOD1G93A mouse model for motor neuron disease. J Biol Chem 2010 0.86
29 Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation. J Gen Virol 2006 0.86
30 A role of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J 2009 0.85
31 The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 2008 0.85
32 The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form. Biochemistry 2010 0.84
33 Inhibition of proteinase K activity by copper(II) ions. Biochemistry 2007 0.81
34 Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity. Biochem J 2006 0.77
35 The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition. J Neuropathol Exp Neurol 2006 0.75